Skip to main content
Top
Published in: Journal of Cancer Education 1/2015

01-03-2015 | Reflection

Five Principles for Effective Cancer Clinical Trial Education Within the Community Setting

Authors: Margo Michaels, Natasha Blakeney, Aisha T. Langford, Marvella E. Ford

Published in: Journal of Cancer Education | Issue 1/2015

Login to get access

Abstract

Participation in cancer clinical trials (CCTs) is a key measure for delivery of quality cancer care. Yet, adult cancer patient participation in CCTs remains at about 3 %, and participation rates are even lower among ethnic and racial minorities and the medically underserved. Social justice demands better representation of all populations in CCTs to ensure equal access to clinical trials and to ensure greater generalizability of trial results. Using a conceptual framework, this paper outlines a set of guiding principles deemed essential for effective and ethical implementation of community-based education in CCTs. Also described are examples of interventions related to this framework that have been used to overcome key barriers to trial enrollment among underserved populations. Application of the key principles, combined with ongoing engagement of cancer care institutions, suggests promise in enhancing trial participation.
Footnotes
1
As described in the Belmont Report,: justice “means the sense of ‘fairness in distribution’ or ‘what is deserved.’” An injustice occurs when some benefit to which a person is entitled is denied without good reason or when some burden is imposed unduly. “Questions of justice have long been associated with social practices such as punishment, taxation and political representation…and have not generally been associated with scientific research. However, conceptions of justice are relevant to research involving human subjects” (http://​www.​hhs.​gov/​ohrp/​humansubjects/​guidance/​belmont.​htm).
 
Literature
2.
go back to reference Nass SJ, Moses HL, Mendelsohn J (eds) (2010) National Cancer Clinical Trials System for the 21st Century: reinvigorating the NCI Cooperative Group Program. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program. Institute of Medicine of the National Academies. Nass SJ, Moses HL, Mendelsohn J (eds) (2010) National Cancer Clinical Trials System for the 21st Century: reinvigorating the NCI Cooperative Group Program. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program. Institute of Medicine of the National Academies.
3.
go back to reference Brawley OW (2004) The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol 22:2039–2040CrossRefPubMed Brawley OW (2004) The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol 22:2039–2040CrossRefPubMed
4.
go back to reference Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. J Am Med Assoc 291:2720–2726CrossRef Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. J Am Med Assoc 291:2720–2726CrossRef
5.
go back to reference Stewart JH, Bertoni AG, Staten JL et al (2007) Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14(12):3328–3334CrossRefPubMed Stewart JH, Bertoni AG, Staten JL et al (2007) Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14(12):3328–3334CrossRefPubMed
6.
go back to reference Simon MS, Du W (2004) Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 22:2046–2052CrossRefPubMed Simon MS, Du W (2004) Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 22:2046–2052CrossRefPubMed
7.
go back to reference Galen J, Dohan D (2009) Diversity of participants in clinical trials in an academic medical center: the role of the ‘good study patient? Cancer 115:608–615CrossRef Galen J, Dohan D (2009) Diversity of participants in clinical trials in an academic medical center: the role of the ‘good study patient? Cancer 115:608–615CrossRef
8.
go back to reference Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented population to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented population to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed
9.
go back to reference Wendler D, Kington R, Madans J et al (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med 3(2):e19, Epub 2005CrossRefPubMedCentralPubMed Wendler D, Kington R, Madans J et al (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med 3(2):e19, Epub 2005CrossRefPubMedCentralPubMed
10.
go back to reference Ford JG, Howerton MW, Bolen S et al (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Summary Evidence Report/Technology Assessment. No. 122. AHRQ Publication No. 05-E019-1. Agency for Healthcare Research and Quality, Rockville Ford JG, Howerton MW, Bolen S et al (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Summary Evidence Report/Technology Assessment. No. 122. AHRQ Publication No. 05-E019-1. Agency for Healthcare Research and Quality, Rockville
11.
go back to reference Ford ME, Siminoff LA, Pickelsimer E et al (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38:29–38CrossRefPubMedCentralPubMed Ford ME, Siminoff LA, Pickelsimer E et al (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38:29–38CrossRefPubMedCentralPubMed
12.
go back to reference Ford ME, Wahlquist AE, Ridgeway C et al (2011) Evaluating an intervention to increase cancer knowledge in racially diverse communities in South Carolina. Patient Educ Couns 83:256–260CrossRefPubMedCentralPubMed Ford ME, Wahlquist AE, Ridgeway C et al (2011) Evaluating an intervention to increase cancer knowledge in racially diverse communities in South Carolina. Patient Educ Couns 83:256–260CrossRefPubMedCentralPubMed
13.
go back to reference Ford ME, Havstad SL, Fields ME et al (2008) Effects of baseline comorbidities on cancer screening trial adherence among older African American men. Canc Epidemiol Biomarkers Prev 17:1234–1239, Epub 2008 May 7CrossRef Ford ME, Havstad SL, Fields ME et al (2008) Effects of baseline comorbidities on cancer screening trial adherence among older African American men. Canc Epidemiol Biomarkers Prev 17:1234–1239, Epub 2008 May 7CrossRef
14.
go back to reference Langford A, Resnicow K, An L (2010) Clinical trial awareness among racial/ethnic minorities in HINTS 2007: sociodemographic, attitudinal, and knowledge correlates. J Health Commun Int Perspect 15(Suppl 3):92–101CrossRef Langford A, Resnicow K, An L (2010) Clinical trial awareness among racial/ethnic minorities in HINTS 2007: sociodemographic, attitudinal, and knowledge correlates. J Health Commun Int Perspect 15(Suppl 3):92–101CrossRef
15.
go back to reference Corbie-Smith G, Thomas SB, St George DMM (2002) Distrust, race, and research. Arch Intern Med 162:2458–2463 Corbie-Smith G, Thomas SB, St George DMM (2002) Distrust, race, and research. Arch Intern Med 162:2458–2463
16.
go back to reference Brown M, Moyer A (2010) Predictors of awareness of clinical trials and feelings about the use of medical information for research in a nationally representative US sample. Ethn Health 15:223–236CrossRefPubMed Brown M, Moyer A (2010) Predictors of awareness of clinical trials and feelings about the use of medical information for research in a nationally representative US sample. Ethn Health 15:223–236CrossRefPubMed
18.
go back to reference Lara PN Jr, Paterniti DA, Chiechi C et al (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23:9282–9289CrossRefPubMed Lara PN Jr, Paterniti DA, Chiechi C et al (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23:9282–9289CrossRefPubMed
19.
go back to reference UyBico SJ, Pavel S, Gross CP (2007) Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med 22:852–863CrossRefPubMedCentralPubMed UyBico SJ, Pavel S, Gross CP (2007) Recruiting vulnerable populations into research: a systematic review of recruitment interventions. J Gen Intern Med 22:852–863CrossRefPubMedCentralPubMed
20.
go back to reference Ellis PM, Butow PN, Tattersall MHN et al (2001) Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 19:3554–3561PubMed Ellis PM, Butow PN, Tattersall MHN et al (2001) Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 19:3554–3561PubMed
21.
go back to reference Baquet CR, Commiskey P, Mullins CD et al (2006) Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev 30:24–33CrossRefPubMedCentralPubMed Baquet CR, Commiskey P, Mullins CD et al (2006) Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev 30:24–33CrossRefPubMedCentralPubMed
22.
go back to reference Michaels M, Weiss ES, Guidry JA et al (2012) The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual. J Cancer Educ 27:67–74CrossRefPubMed Michaels M, Weiss ES, Guidry JA et al (2012) The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual. J Cancer Educ 27:67–74CrossRefPubMed
23.
go back to reference Ford M, Wahlquist A, Blake R et al (2012) Assessing an intervention to improve clinical trial perceptions among predominately African-American communities in South Carolina. Prog Community Health Partnerships Res Educ Action 6:249–263CrossRef Ford M, Wahlquist A, Blake R et al (2012) Assessing an intervention to improve clinical trial perceptions among predominately African-American communities in South Carolina. Prog Community Health Partnerships Res Educ Action 6:249–263CrossRef
24.
go back to reference Ford ME, Havstad SL, Vernon SW et al (2006) Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial. The Gerontologist 46:545–550CrossRefPubMed Ford ME, Havstad SL, Vernon SW et al (2006) Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial. The Gerontologist 46:545–550CrossRefPubMed
25.
go back to reference Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M (2014) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomarkers Prev 23(3):424–432, Oct 3 Epub 2013CrossRefPubMed Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M (2014) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomarkers Prev 23(3):424–432, Oct 3 Epub 2013CrossRefPubMed
26.
go back to reference Blakeney N, Michaels M, Green M, Richmond A, Long D, Robinson WS, Spicer C, Elliott-Bynum S, Corbie-Smith G (in press) Collaborative development of clinical trials education programs for African-American community-based organizations. J Canc Educ Blakeney N, Michaels M, Green M, Richmond A, Long D, Robinson WS, Spicer C, Elliott-Bynum S, Corbie-Smith G (in press) Collaborative development of clinical trials education programs for African-American community-based organizations. J Canc Educ
Metadata
Title
Five Principles for Effective Cancer Clinical Trial Education Within the Community Setting
Authors
Margo Michaels
Natasha Blakeney
Aisha T. Langford
Marvella E. Ford
Publication date
01-03-2015
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 1/2015
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0699-6

Other articles of this Issue 1/2015

Journal of Cancer Education 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine